The impact of vedolizumab and ustekinumab on arthropathy and arthralgia in IBD patients: a real-life multicentric cohort study

被引：3
|
作者：
Truyens, M. [1 ,2 ,3 ,4 ]
De Galan, C. [1 ,3 ,4 ]
Peeters, H. [5 ]
Mesonero Gismero, F. [6 ]
Elorza, A. [7 ]
Torres, P. [8 ]
Vandermeulen, L. [9 ]
Amezaga, A. Jauregui [10 ]
Ferreiro-Iglesias, R. [11 ]
Holvoet, T. [12 ]
Zabana, Y. [13 ,14 ]
Reverter, L. Peries [15 ]
Geldof, J. [2 ]
Varkas, G. [4 ,16 ]
De Vos, M. [1 ,2 ,3 ]
Lobaton, T. [1 ,2 ]
机构：
[1] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium
[2] Univ Hosp Ghent, Dept Gastroenterol, Ghent, Belgium
[3] Univ Ghent, Ghent Gut Inflammat Grp GGIG, Ghent, Belgium
[4] Univ Ghent, VIB Ctr Inflammat Res IRC, Ghent, Belgium
[5] AZ Sint Lucas, Dept Gastroenterol, Ghent, Belgium
[6] Hosp Ramon & Cajal, Dept Gastroenterol, Madrid, Spain
[7] Hosp Galdakao, Dept Gastroenterol, Bilbao, Spain
[8] Hosp Badalona Germans Trias & Pujol, Dept Gastroenterol, Barcelona, Spain
[9] Vrije Univ Brussel VUB, Univ Ziekenhuis Brussel, Dept Gastroenterol, Brussels, Belgium
[10] Univ Hosp Antwerp, Dept Gastroenterol, Antwerp, Belgium
[11] Hosp Clin Univ Santiago, Dept Gastroenterol, Santiago De Compostela, Spain
[12] AZ Nikolaas, Dept Gastroenterol, St Niklaas, Belgium
[13] Hosp Univ Mutua Terrassa, Dept Gastroenterol, Barcelona, Spain
[14] Hosp Univ Mutua Terrassa, CIBERehd, Barcelona, Spain
[15] Hosp Univ Girona, Dept Gastroenterol, Girona, Spain
[16] Univ Hosp Ghent, Dept Rheumatol, Ghent, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.391
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P266
引用
收藏
页码：S302 / S302
页数：1
相关论文
共 50 条
  • [41] Arthralgia and myalgia associated with aromatase inhibitors: frequency and characterization in real-life patients
    Camejo, Natalia
    Castillo, Cecilia
    Santana, Diego
    Argenzio, Lucia
    Amarillo, Dahiana
    Herrera, Guadalupe
    Guerrina, Maria
    Krygier, Gabriel
    ECANCERMEDICALSCIENCE, 2024, 18
  • [42] Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study
    Tursi, Antonio
    Mocci, Giammarco
    Scaldaferri, Franco
    Napolitano, Daniele
    Maresca, Rossella
    Pugliese, Daniela
    Semprucci, Gianluca
    Savarino, Edoardo
    Cuomo, Antonio
    Donnarumma, Laura
    Bodini, Giorgia
    Pasta, Andrea
    Maconi, Giovanni
    Cataletti, Giovanni
    Pranzo, Giuseppe
    Rodino, Stefano
    Sebkova, Ladislava
    Costa, Francesco
    Ferronato, Antonio
    Gaiani, Federica
    Marzo, Manuela
    Luppino, Ileana
    Fabiano, Giulia
    Paese, Pietro
    Elisei, Walter
    Monterubbianesi, Rita
    Faggiani, Roberto
    Grossi, Laurino
    Serio, Mariaelena
    Scarcelli, Antonella
    Lorenzetti, Roberto
    Allegretta, Leonardo
    Chiri, Stefania
    Grasso, Giuseppina
    Antonelli, Elisabetta
    Bassotti, Gabrio
    Spagnuolo, Rocco
    Luzza, Francesco
    Fanigliulo, Libera
    Rocco, Giulia
    Sacchi, Carlotta
    Zampaletta, Costantino
    Rocchi, Chiara
    Bolognini, Laura
    Bendia, Emanuele
    Bianco, Maria Antonia
    Capone, Pietro
    Meucci, Costantino
    Colucci, Raffaele
    Tonti, Paolo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (1-2) : 101 - 109
  • [43] Effectiveness of ustekinumab in patients with refractory Crohn's disease: a multicentre real-life study in Italy
    Scribano, Maria Lia
    Aratari, Annalisa
    Neri, Benedetto
    Bezzio, Cristina
    Balestrieri, Paola
    Baccolini, Valentina
    Falasco, Giuliano
    Camastra, Caterina
    Pantanella, Paolo
    Monterubbianesi, Rita
    Tullio, Alessandro
    Saibeni, Simone
    Papi, Claudio
    Biancone, Livia
    Cosintino, Rocco
    Faggiani, Roberto
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [44] Ustekinumab safety and effectiveness in ulcerative colitis patients: results from a large real-life study
    Mocci, G.
    Scaldaferri, F.
    Pugliese, D.
    Savarino, E.
    Bodini, G.
    Cuomo, A.
    Donnarumma, L.
    Maconi, G.
    Cataletti, G.
    Rodino, S.
    Sebkova, L.
    Ferronato, A.
    Gaiani, F.
    Marzo, M.
    Luppino, I.
    Paese, P.
    Elisei, W.
    Monterubbianesi, R.
    Faggiani, R.
    Napolitano, D.
    Grossi, L.
    Serio, M.
    Scarcelli, A.
    Lorenzetti, R.
    Allegretta, L.
    Rocco, G.
    Zampaletta, C.
    Bolognini, L.
    Meucci, C.
    Colucci, R.
    Tonti, P.
    Della Valle, N.
    Piga, R.
    Forti, G.
    Onidi, F. M.
    Satta, P. Usai
    Picchio, M.
    Papa, A.
    Tursi, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1065 - I1066
  • [45] Impact of gender on COPD expression in a real-life cohort
    Nicolas Roche
    Gaetan Deslée
    Denis Caillaud
    Graziella Brinchault
    Isabelle Court-Fortune
    Pascale Nesme-Meyer
    Pascale Surpas
    Roger Escamilla
    Thierry Perez
    Pascal Chanez
    Christophe Pinet
    Gilles Jebrak
    Jean-Louis Paillasseur
    Pierre-Régis Burgel
    Respiratory Research, 15
  • [46] Effectiveness and persistence of vedolizumab in patients with Inflammatory bowel Disease: Results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)
    Reenaers, C.
    Cremer, A.
    Dewit, O.
    de Vroey, B.
    Van Moerkercke, W.
    Bossuyt, P.
    Muls, V.
    Imschoot, J.
    Block, S.
    Hantson, A.
    Van Hootegem, P.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S476 - S477
  • [47] Impact of gender on COPD expression in a real-life cohort
    Roche, Nicolas
    Deslee, Gaetan
    Caillaud, Denis
    Brinchault, Graziella
    Court-Fortune, Isabelle
    Nesme-Meyer, Pascale
    Surpas, Pascale
    Escamilla, Roger
    Perez, Thierry
    Chanez, Pascal
    Pinet, Christophe
    Jebrak, Gilles
    Paillasseur, Jean-Louis
    Burgel, Pierre-Regis
    RESPIRATORY RESEARCH, 2014, 15
  • [48] The Real-Life Experience of Vedolizumab Efficacy and Safety in Crohn's Disease: A Prospective Observational Multicenter Cohort Study
    Amiot, Aurelien
    Grimaud, Jean-charles
    Treton, Xavier
    Filippi, Jerome
    Pariente, Benjamin
    Peyrin-Biroulet, Laurent
    Boureille, Arnaud
    Buisson, Anthony
    Carbonnel, Franck
    Bourrier, Anne
    Nancey, Stephane
    Roblin, Xavier
    Marteau, Philippe R.
    Altwegg, Romain
    Moreau, Jacques
    Aubourg, Alexandre
    Savoye, Guillaume
    Pelletier, Anne Laure
    Fumery, Mathurin
    Bonaz, Bruno L.
    Bouhnik, Yoram
    GASTROENTEROLOGY, 2016, 150 (04) : S810 - S810
  • [49] Effectiveness and persistence of Vedolizumab in patients with inflammatory bowel disease : results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE)
    Reenaers, C.
    Cremer, A.
    Dewit, O.
    De Vroey, B.
    Van Moerkercke, W.
    Bossuyt, P.
    Muls, V
    Imschoot, J.
    Block, S.
    Hantson, A.
    Van Hootegem, P.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2020, 83 (01) : 15 - 23
  • [50] The real-life experience of vedolizumab efficacy and safety in Crohn's disease: a prospective observational multicentre cohort study
    Amiot, A.
    Grimaud, J. C.
    Treton, X.
    Filippi, J.
    Pariente, B.
    Peyrin-Biroulet, L.
    Noureille, A.
    Buisson, A.
    Carbonnel, F.
    Bourrier, A.
    Nancey, S.
    Roblin, X.
    Marteau, P.
    Altwegg, R.
    Moreau, J.
    Aubourg, A.
    Savoye, G.
    Pelletier, A. L.
    Fumery, M.
    Bonaz, B.
    Bouhnik, Y.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S313 - S314
12345